Company Filing History:
Years Active: 2015-2017
Title: Innovations of Inventor Alex Bush
Introduction
Alex Bush is a notable inventor based in Brighton, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of innovative proteins for therapeutic applications. With a total of three patents to his name, Bush is recognized for his work in addressing autoimmune diseases.
Latest Patents
Among his latest patents, Bush has developed fibronectin-based scaffold domain proteins that bind interleukin 23 (IL-23). This invention specifically targets the p19 subunit of IL-23, which plays a crucial role in autoimmune responses. The innovative proteins have potential therapeutic applications, offering new avenues for treatment. Additionally, the invention encompasses cells that contain these proteins, polynucleotides encoding the proteins or their fragments, and vectors that include the polynucleotides.
Career Highlights
Bush is currently employed at Bristol-Myers Squibb Company, where he continues to advance his research and development efforts. His work is pivotal in the ongoing fight against autoimmune diseases, showcasing his commitment to improving patient outcomes through scientific innovation.
Collaborations
Throughout his career, Bush has collaborated with talented individuals such as Ruchira Dasgupta and Linda Engle. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
In summary, Alex Bush is a distinguished inventor whose work in developing fibronectin-based scaffold domain proteins has the potential to revolutionize treatments for autoimmune diseases. His contributions to biotechnology and collaboration with esteemed colleagues highlight his dedication to innovation in the field.